BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37909952)

  • 1. Preoperative and Postoperative C-Reactive Protein to Albumin Ratio (CAR) as a Prognostic Marker for Survival of Esophageal Squamous Cell Carcinoma Patients After Surgery.
    Asaka S; Shimakawa T; Nishiguchi R; Yamaguchi K; Murayama M; Usui T; Yokomizo H; Shiozawa S
    Anticancer Res; 2023 Nov; 43(11):5139-5147. PubMed ID: 37909952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study.
    Sugimoto A; Toyokawa T; Miki Y; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
    BMC Surg; 2021 Sep; 21(1):348. PubMed ID: 34548054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
    Huang W; Wu L; Liu X; Long H; Rong T; Ma G
    J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer.
    Ibuki Y; Hamai Y; Hihara J; Emi M; Taomoto J; Furukawa T; Yamakita I; Kurokawa T; Okada M
    World J Surg; 2017 Jun; 41(6):1558-1565. PubMed ID: 28120093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
    Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
    Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Immunoinflammatory Measures and Periostin Expression in Esophageal Squamous Cell Carcinoma: A Single-Center, Retrospective Cohort Study.
    Ishibashi Y; Tsujimoto H; Einama T; Mochizuki S; Kouzu K; Nomura S; Ito N; Harada M; Sugasawa H; Shinto E; Kishi Y; Ueno H
    Ann Surg Oncol; 2021 Feb; 28(2):1228-1237. PubMed ID: 32613365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative inflammatory markers predict survival in patients after McKeown esophagectomy for esophageal cancer.
    Takahashi K; Masuda T; Ishikawa Y; Tanishima Y; Kurogochi T; Yuda M; Tanaka Y; Matsumoto A; Yano F; Eto K
    J Surg Oncol; 2023 Aug; 128(2):196-206. PubMed ID: 37010064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention.
    Fujiwara Y; Endo S; Higashida M; Kubota H; Yoshimatsu K; Ueno T
    Esophagus; 2023 Apr; 20(2):234-245. PubMed ID: 36327058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases.
    Teranishi R; Makino T; Tanaka K; Yamashita K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Yamasaki M; Nakajima K; Eguchi H; Doki Y
    Surgery; 2023 Sep; 174(3):558-566. PubMed ID: 37385868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma.
    Hu SJ; Zhao XK; Song X; Lei LL; Han WL; Xu RH; Wang R; Zhou FY; Wang L; Wang LD
    World J Gastroenterol; 2021 Jan; 27(4):321-335. PubMed ID: 33584065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
    Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
    PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Systemic Inflammatory Score Combined With Immunoinflammatory Markers Accurately Reflects Prognosis in Patients With Esophageal Cancer.
    Suzuki T; Ishibashi Y; Tsujimoto H; Nomura S; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Sugasawa H; Kishi Y; Ueno H
    In Vivo; 2020; 34(6):3705-3711. PubMed ID: 33144487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The duration of systemic inflammatory response syndrome is a reliable indicator of long-term survival after curative esophagectomy for esophageal squamous cell carcinoma.
    Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Maeda K; Ohira M
    Esophagus; 2021 Jul; 18(3):548-558. PubMed ID: 33591543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
    Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
    Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
    Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
    J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Postoperative CRP and Prognosis in Thoracic Esophageal Squamous Cell Carcinoma.
    Katsurahara K; Shiozaki A; Fujiwara H; Konishi H; Kudou M; Shoda K; Arita T; Kosuga T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Kubota T; Nakanishi M; Okamoto K; Otsuji E
    Anticancer Res; 2018 Nov; 38(11):6513-6518. PubMed ID: 30396980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.